What does the paper add to the literature?The paper describes sexual dysfunction in an unselected cohort of patients with rectal cancer. Therefore, it reflects the effects of treatment in a wider perspective than previous literature. It highlights the problems encountered by patients with rectal cancer and shows that few patients receive supportive treatment.

Introduction {#codi14907-sec-0006}
============

Colorectal cancer is the third most common cancer in the world [1](#codi14907-bib-0001){ref-type="ref"}. There have been major improvements in both survival and local recurrence rates in the past decades due to improved treatment [2](#codi14907-bib-0002){ref-type="ref"}, [3](#codi14907-bib-0003){ref-type="ref"}. Today almost 80% are treated with curative intent. Treatment‐related morbidity, however, remains high and many patients have challenges related to their stoma as well as bowel, urinary or sexual function [4](#codi14907-bib-0004){ref-type="ref"}, [5](#codi14907-bib-0005){ref-type="ref"}, [6](#codi14907-bib-0006){ref-type="ref"}, [7](#codi14907-bib-0007){ref-type="ref"}, [8](#codi14907-bib-0008){ref-type="ref"}.

The incidence of sexual dysfunction among patients with rectal cancer varies in the literature from 5% to 88% [9](#codi14907-bib-0009){ref-type="ref"}, [10](#codi14907-bib-0010){ref-type="ref"}. This may be due to the lack of a common definition of sexual dysfunction which leads to difficulties in comparing results [10](#codi14907-bib-0010){ref-type="ref"}. Recently, an attempt has been made to develop a short seven‐item scale to evaluate female sexual function [11](#codi14907-bib-0011){ref-type="ref"}. However, this has yet to be tested in larger populations.

The cause of sexual dysfunction may be the surgery itself with potential nerve damage, especially during abdominoperineal excision for low rectal tumours [12](#codi14907-bib-0012){ref-type="ref"}, [13](#codi14907-bib-0013){ref-type="ref"}, [14](#codi14907-bib-0014){ref-type="ref"}. It has been suggested that minimally invasive techniques could reduce nerve damage and enhance the recovery of (uro)genital function but this has not been corroborated in larger studies [15](#codi14907-bib-0015){ref-type="ref"}, [16](#codi14907-bib-0016){ref-type="ref"}, [17](#codi14907-bib-0017){ref-type="ref"}.

Other possible risk factors for sexual dysfunction and low sexual activity are age, gender, neoadjuvant chemo/radiotherapy, advanced tumour stage and the presence of a stoma [14](#codi14907-bib-0014){ref-type="ref"}, [18](#codi14907-bib-0018){ref-type="ref"}, [19](#codi14907-bib-0019){ref-type="ref"} as well as psychosocial factors such as depression and the patient's social situation [20](#codi14907-bib-0020){ref-type="ref"}.

The primary aim of this study was to describe the prevalence of sexual dysfunction in an unselected patient cohort prior to treatment and 1 year after the diagnosis of rectal cancer. A secondary aim was to identify risk factors for low sexual activity 1 year after diagnosis.

Method {#codi14907-sec-0007}
======

Patient selection and inclusion {#codi14907-sec-0008}
-------------------------------

The QoLiRECT (Quality of Life in RECTal cancer) study prospectively included 1248 patients recruited from 16 colorectal units in Denmark and Sweden between 2012 and 2015. All patients with a biopsy‐confirmed rectal adenocarcinoma within 15 cm from the anal verge, irrespective of tumour stage or treatment plan, who gave informed consent and were above 18 years of age were included. Details of the protocol have been described previously [21](#codi14907-bib-0021){ref-type="ref"}. During the study period, 3490 patients were registered in the Swedish and Danish national quality registries by participating centres. Of these, 2242 did not meet the inclusion criteria or were not asked to participate [22](#codi14907-bib-0022){ref-type="ref"}. A high response rate of the questionnaires was achieved through personal contact with all patients at inclusion as well as at follow‐up.

In short, the patients were included after diagnosis but prior to the start of treatment. Questionnaires were administered to each patient at inclusion and after 1, 2 and 5 years. The present analysis is based on the answers related to sexual function at inclusion and 1 year after diagnosis.

The questionnaire {#codi14907-sec-0009}
-----------------

The questionnaire was developed using a process of in‐depth interviews with patients with rectal cancer, followed by a qualitative analysis, construction of questions, content validation in a multidisciplinary group and a face‐to‐face validation. This process has been used previously and some of the questions have been used in studies on patients treated for rectal cancer, prostate cancer and cervical cancer [22](#codi14907-bib-0022){ref-type="ref"}, [23](#codi14907-bib-0023){ref-type="ref"}, [24](#codi14907-bib-0024){ref-type="ref"}, [25](#codi14907-bib-0025){ref-type="ref"}, [26](#codi14907-bib-0026){ref-type="ref"}. The time frame for answers was set to 1 month to reduce the risk of recall bias [25](#codi14907-bib-0025){ref-type="ref"}, [27](#codi14907-bib-0027){ref-type="ref"}. For this study, we analysed questions relevant to sexual function.

Reference population {#codi14907-sec-0010}
--------------------

We have previously evaluated the sexual function and sexual life within a population of 1078 randomly selected Swedish men and women with a median age of 63 years (range 31--90) [28](#codi14907-bib-0028){ref-type="ref"}. Initially, 3000 individuals randomly selected by the Swedish Tax Agency were contacted by letter and telephone. The recruited individuals completed a questionnaire similar to the study questionnaire and the results have been used for comparison in both this and other studies [22](#codi14907-bib-0022){ref-type="ref"}, [29](#codi14907-bib-0029){ref-type="ref"}.

Sexual function {#codi14907-sec-0011}
---------------

The questions were divided into male and female sexual function. Female sexual function focused on adequate/subjective physical reaction of sexual arousal described as genital swelling and lubrication during the last month. The presence of dyspareunia during intercourse or other sexual activity was also analysed. In the reference population, both deep and superficial pain were explored. This was combined into one variable for the analysis.

In men, erectile dysfunction was explored in the baseline questionnaire and the reference population using a yes/no question regarding weak erection. In the follow‐up questionnaire, the presence of dysfunction was derived from the responses to a question regarding the effect of erectile dysfunction on self‐esteem. Premature and retrograde ejaculation during the last month were evaluated in the reference population and at 1 year among the study population.

Frequency of sexual activity {#codi14907-sec-0012}
----------------------------

The frequency of sexual activity was obtained from the questions 'How often have you had intercourse or other sexual activity in the last month?', 'Have you had thoughts about sex in the last month?', 'Has sex been important for you in the last month?', 'Have you felt sexually attractive in the last month?' and the answers were dichotomized to 'no activity' *vs* 'any activity'.

Quality of sexual life {#codi14907-sec-0013}
----------------------

The quality of sexual life was derived from the questions 'Are you satisfied with your sexual life' and 'Would you be distressed if the sexual problems/erectile dysfunction you experienced within the last month would remain the rest of your life?' The ability to achieve orgasm was analysed in both sexes 1 year after diagnosis.

Information regarding sexual dysfunction by healthcare givers {#codi14907-sec-0014}
-------------------------------------------------------------

Whether patients received information regarding possible sexual dysfunction prior to treatment was evaluated by a yes/no question at baseline and after 1 year. To further address this issue, we also evaluated how many patients had sought medical help for sexual problems after treatment.

Clinical data {#codi14907-sec-0015}
-------------

Clinical data were retrieved from the national registries for colorectal cancer, in Sweden the Swedish Colorectal Cancer Registry (SCRCR) and in Denmark the Danish Colorectal Cancer Group (DCCG). Data on sex, age, American Society of Anesthesiologists classification (ASA), tumour stage \[Union Internationale Contre le Cancer (UICC) classification\], chemotherapy and/or radiotherapy, body mass index, type of surgery, technique (laparoscopic or open) and perioperative blood loss were collected. As some of the surgical and oncological data in the DCCG registry were lacking compared to the SCRCR, a clinical record form was developed at the study secretariat and filled out retrospectively by personnel at the participating Danish hospitals. Data regarding preoperative and postoperative chemotherapy, preoperative radiotherapy and type of surgery were collected. In the SCRCR, data were frequently missing on adjuvant chemotherapy. This information was added from the 1‐year follow‐up QoLiRECT questionnaire.

Statistical analysis {#codi14907-sec-0016}
--------------------

Results are presented as numbers and percentages. Where the alternative 'Not applicable, I have not had any sexual activity in the last month' was possible, the percentages were calculated using only the sexually active patients.

Frequency of sexual activity and quality of sexual life as addressed by the four questions 'Have you longed for sexual activity?' (yes *vs* no), 'Has sex been of importance for you?' (yes *vs* no), 'How often have you had intercourse or other sexual activity?' (never *vs* once or more frequent) and 'Have you been content with your sex life?' (yes *vs* no), with a recall period of 1 month, were compared with the reference population in a gender‐ and age‐adjusted analysis using a log‐binomial regression with sex and age included as covariates. Results are presented graphically as prevalence estimates with 95% confidence intervals.

In the analysis of potential risk factors for absence of sexual activity after 1 year ('How often have you had intercourse or other sexual activity in the last month?'), two types of variables were evaluated: those related to preoperative patient characteristics (sexual activity at diagnosis, age, sex, marital status and comorbidity) and those related to the intra‐operative and postoperative phase \[UICC, preoperative chemoradiotherapy, radiation therapy, postoperative chemotherapy, type of surgery (anterior resection, abdominoperineal excision, Hartmann's procedure, other or no operation performed), technique (laparoscopy *vs* open), stoma ('Have you had a stoma during the last year?') and the presence of a depressed mood ('Would you consider yourself depressed?', response options yes/don't know *vs* no) at 1 year\] [30](#codi14907-bib-0030){ref-type="ref"}. As the type of surgery is associated with the risk of having a stoma, the type of surgery and the question regarding stoma were combined into a single variable with three categories: (i) abdominoperineal excision (a stoma is mandatory); (ii) surgery/no surgery without a stoma; (iii) anterior resection/Hartmann's procedure/other with a stoma.

Based on exploratory logistic regression analyses it was concluded that age, sex and marital status were associated with sexual activity both in the reference population and among patients at the time of diagnosis. It was further found that absence of sexual activity at diagnosis had a strong association with subsequent absence at 1 year. Therefore, in the analysis of activity at 1 year intra‐operative and postoperative variables were considered. Sexual activity at diagnosis was included as a covariate in the regression models. The variables were evaluated using simple and multiple logistic regression. As a means for selecting the risk factors with the strongest associations the purposeful selection strategy for logistic regression was used [31](#codi14907-bib-0031){ref-type="ref"}. The selection strategy consists of iteratively including and excluding variables from a multiple regression model based both on the explanatory power of the dependent variable as well as in the magnitude of the estimated regression coefficients between the different models. The SAS macro used to automatically perform the purposeful selection strategy used default values of the macro variables. The final step in the analysis involved replacement of missing values for the variables selected from the strategy using multiple imputations by chained equations [32](#codi14907-bib-0032){ref-type="ref"} and the subsequent estimation and pooling of the final multiple regression model by using proc mianalyze in SAS. Local recurrence at 1 year was considered a potential risk factor, but as the number of patients with a local recurrence at 1 year remains low it was not considered.

Results {#codi14907-sec-0017}
=======

The questionnaire was completed by 1085 patients at inclusion and 920 patients after 1 year (Fig. [1](#codi14907-fig-0001){ref-type="fig"}). At 1 year, 49 patients had died. Among non‐responders at 1 year there were more patients with advanced tumours and patients without surgical intervention compared to responders [33](#codi14907-bib-0033){ref-type="ref"}. There were 63% men in the cohort and more men than women were in a relationship (Table [1](#codi14907-tbl-0001){ref-type="table"}). About half of the procedures were anterior resection and half were performed laparoscopically (Table [1](#codi14907-tbl-0001){ref-type="table"}). Compared with the reference population, the patients were similar regarding lifestyle factors such as smoking, physical activity and body mass index but had a lower alcohol consumption (Table [1](#codi14907-tbl-0001){ref-type="table"}).

![Flowchart of patients included in the analyses at baseline and the 1‐year follow‐up. Note that 33 patients answered the questionnaire at the 1‐year follow‐up but not at baseline. \*Baseline questionnaire was distributed after diagnosis, prior to the start of treatment.](CODI-22-500-g001){#codi14907-fig-0001}

###### 

Baseline demography and patient characteristics of the QoLiRECT cohort and the reference cohort.

  Variable                                                          Category                        QoLiRECT cohort   Reference cohort                                                                        
  ----------------------------------------------------------------- ------------------------------- ----------------- ------------------ --------------- ---------- ------------- ------------- ------------- -----
  Age                                                               Median (range)                  68 (25--93)       69 (38--100)       69 (25--100)    0          61 (31--90)   64 (32--90)   63 (31--90)   0
  BMI (m/l^2^)                                                      Median (range)                  25 (22--28)       26 (24--29)        26 (23--29)     162        25 (17--47)   26 (18--49)   25 (17--49)   33
  In a relationship                                                 Yes                             260 (67)          536 (78)           796 (74)        11         408 (72)      413 (81)      821 (77)      6
  No                                                                127 (33)                        151 (22)          278 (26)                           154 (28)   97 (19)       258 (23)                    
  Current smoker                                                    Yes                             34 (9)            65 (10)            99 (9)          20         74 (13)       65 (13)       139 (13)      10
  No                                                                353 (91)                        613 (90)          966 (91)                           489 (87)   440 (87)      929 (87)                    
  Alcohol intake                                                    More than 16 glasses per week   4 (1)             34 (5)             38 (4)          46         116 (26)      126 (28)      242 (27)      186
  Less than 16 glasses per week                                     370 (99)                        631 (95)          1001 (96)                          329 (74)   321 (72)      650 (73)                    
  Physical activity (%)                                             Physically inactive             54 (14)           102 (15)           156 (15)        48         77 (14)       71 (14)       148 (14)      30
  Some light physical activity or more                              324 (86)                        557 (85)          881 (85)                           470 (86)   430 (84)      900 (86)                    
  ASA classification                                                ASA I                           96 (27)           139 (23)           235 (25)        133                                                   
  ASA II                                                            213 (61)                        351 (58)          564 (59)                                                                                
  ASA III--IV                                                       42 (12)                         111 (18)          153 (16)                                                                                
  Comorbidity[\*](#codi14907-note-0003){ref-type="fn"}              Yes                             234 (60)          427 (62)           661 (62)        12         310 (55)      271 (53)      581 (54)      1
  No                                                                153 (40)                        259 (38)          412 (38)                           256 (45)   240 (47)      496 (46)                    
  Depression                                                        Yes/I don't know                87 (22)           94 (14)            181 (17)        9          86 (15)       63 (12)       149 (14)      10
  No                                                                304 (78)                        591 (86)          895 (83)                           474 (85)   445 (88)      919 (86)                    
  Curative intention                                                                                375 (96)          637 (92)           1012 (93)       0                                                     
  Palliative intention                                                                              17 (4)            56 (8)             73 (7)          0                                                     
  UICC classification[†](#codi14907-note-0004){ref-type="fn"} (%)   0                               6 (2)             12 (2)             18 (2)          140                                                   
  I                                                                 114 (33)                        164 (27)          278 (29)                                                                                
  II                                                                80 (23)                         144 (24)          224 (24)                                                                                
  III                                                               110 (32)                        186 (31)          296 (31)                                                                                
  IV                                                                35 (10)                         94 (16)           129 (14)                                                                                
  Preoperative radiation therapy (%)                                Yes                             152 (39)          228 (33)           380 (35)        0                                                     
  No                                                                240 (61)                        465 (67)          705 (65)                                                                                
  Preoperative chemoradiotherapy (%)                                Yes                             63 (16)           154 (22)           217 (20)        0                                                     
  No                                                                329 (84)                        539 (78)          868 (80)                                                                                
  Postoperative chemotherapy (%)                                    Yes                             145 (39)          246 (38)           391 (38)        64                                                    
  No                                                                226 (61)                        404 (62)          630 (62)                                                                                
  Operative technique (%)                                           Open                            162 (46)          299 (50)           461 (48)        133                                                   
  Laparoscopic                                                      190 (54)                        301 (50)          491 (52)                                                                                
  Type of surgery (%)                                               Anterior resection              209 (56)          293 (45)           502 (49)        56                                                    
  Abdominoperineal resection                                        108 (29)                        223 (34)          331 (32)                                                                                
  Hartmann's procedure                                              24 (6)                          64 (10)           88 (9)                                                                                  
  No intervention                                                   19 (5)                          48 (7)            67 (7)                                                                                  
  Other[‡](#codi14907-note-0005){ref-type="fn"}                     15 (4)                          26 (4)            41 (4)                                                                                  
  Perioperative blood loss, ml (range)                                                              150 (50--300)     250 (100--500)     200 (50--450)   166                                                   

ASA, American Society of Anesthesiologists; BMI, body mass index; UICC, Union Internationale Contre le Cancer. Percentages are in parentheses.

Comorbidity was characterized by a number of health conditions, including joint disorders, cardiovascular, neurological, pulmonary, renal, bowel and psychological conditions as well as diabetes and chronic pain, and was defined as the presence of at least one of these conditions.

UICC is based on the pTNM classification.

Other includes colectomy, Transanal endoscopic microsurgery (TEM), local excision, laparotomy without excision and unknown.
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Sexual function {#codi14907-sec-0018}
---------------

More than half of the women with rectal cancer (59%--75%) chose the answer category 'not applicable, I have not had sexual activity or been sexually aroused within the last month' on one or several of the questions regarding sexual function. This was higher compared with the reference population (39%--45%). Women with rectal cancer generally had poorer sexual function compared with the reference population both at baseline and at 1 year. Dyspareunia increased almost twofold 1 year after diagnosis and there was a 50% increase of insufficient lubrication (Table [2](#codi14907-tbl-0002){ref-type="table"}).

###### 

Sexual function.

  Category                                                    QoLiRECT cohort   Reference cohort   
  ----------------------------------------------------------- ----------------- ------------------ --------------
  Genital swelling during sexual stimulation the last month                                        
  Yes                                                         49/93 (53)        53/87 (61)         250/323 (77)
  No                                                          44/93 (47)        34/87 (39)         73/323 (23)
  Not applicable                                              262/355 (74)      227/314 (72)       218/541 (40)
  Missing                                                     37                33                  
  Lubrication                                                                                      
  Sufficient                                                  65/144 (45)       33/133 (25)        324/331 (98)
  Insufficient                                                79/144 (55)       100/133 (75)       7/331 (2)
  Not applicable                                              217/361 (60)      189/322 (59)       213/544 (39)
  Missing                                                     31                25                 22
  Dyspareunia                                                                                      
  No                                                          78/103 (76)       42/80 (53)         219/296 (74)
  Yes, at least a little                                      25/103 (24)       38/80 (47)         77/296 (26)
  Not applicable                                              262/365 (72)      244/324 (75)       242/538 (45)
  Missing                                                     27                23                 28

                           Men (at baseline) (*n* = 693) (%)   Men (1 year after diagnosis) (*n* = 573) (%)   Men (*N* = 512)
  ------------------------ ----------------------------------- ---------------------------------------------- -----------------
  Erectile dysfunction                                                                                        
  Yes                      299/655 (46)                        300/547 (55)                                   133/505 (26)
  No                       356/655 (54)                        87/547 (16)                                    349/505 (69)
  Don't know                                                   160/547 (29)                                   23/505 (5)
  Missing                  38                                  26                                             7
  Retrograde ejaculation                                                                                      
  Yes                                                          74/215 (34)                                    41/311 (13)
  No                                                           141/215 (66)                                   270/311 (87)
  Not applicable                                               334/549 (61)                                   197/508 (39)
  Missing                                                      24                                             4
  Premature ejaculation                                                                                       
  Yes                                                          36/187 (19)                                    52/294 (18)
  No                                                           152/187 (81)                                   242/294 (82)
  Not applicable                                               360/548 (66)                                   211/505 (42)
  Missing                                                      25                                             7

John Wiley & Sons, Ltd

Among sexually active men retrograde ejaculation was three times as common in patients with rectal cancer at 1 year compared with the reference population. Erectile dysfunction was almost twice as common in men with rectal cancer at baseline (46%) compared with the reference population and was increased to 55% at 1 year (Table [2](#codi14907-tbl-0002){ref-type="table"}). Premature ejaculation did not differ between patients at 1 year and the reference population.

Sexual activity {#codi14907-sec-0019}
---------------

At baseline, about one‐third of the women had thoughts about sex, found sex important and had been sexually active within the last month. Results were similar at 1 year except that there was a 50% reduction in the number of women who included intercourse as a part of their sex life.

At baseline, almost 60% of the men had thoughts about sex, 50% found sex important and 41% had been sexually active within the last month. At 1 year, the number of men who had thoughts about sex and found sex important had increased compared to baseline, but the rate of patients with intercourse as part of their sex life was half compared to baseline. Compared with the age‐matched reference population, patients with rectal cancer generally had fewer thoughts about sex, found sex less important and had a lower sexual activity (Table [3](#codi14907-tbl-0003){ref-type="table"} and Fig. [2](#codi14907-fig-0002){ref-type="fig"}).

###### 

Sexual activity and quality of sexual life.

                                                                                                              QoLiRECT cohort   Reference cohort                                                  
  ----------------------------------------------------------------------------------------------------------- ----------------- ------------------ --------------- -------------- --------------- ---------------
  Thought about sex the last month?                                                                                                                                                               
  Yes, at least a little                                                                                      121/371 (33)      123/331 (37)       395/671 (59)    411/556 (74)   389/555 (70)    452/509 (89)
  No                                                                                                          250/371 (67)      208/331 (63)       276/671 (41)    145/556 (26)   166/555 (30)    57/509 (11)
  Missing                                                                                                     21                16                 22              17             11              3
  Has sex been important to you within the last month?                                                                                                                                            
  Yes, at least a little                                                                                      116/371 (31)      96/330 (29)        327/668 (49)    319/553 (58)   336/554 (61)    365/508 (72)
  No                                                                                                          255/371 (69)      234/330 (71)       341/668 (51)    234/553 (42)   218/554 (39)    143/508 (28)
  Missing                                                                                                     21                17                 25              20             12              4
  Have you felt attractive within the last month?                                                                                                                                                 
  Yes, at least a little                                                                                      116/368 (32)      102/328 (31)       279/660 (42)    212/550 (39)   309/551 (56)    296/508 (58)
  No                                                                                                          252/368 (68)      226/328 (69)       381/660 (58)    338/550 (61)   242/551 (44)    212/508 (42)
  Missing                                                                                                     24                19                 33              23             15              4
  Have you refrained from sex due to risk of failure?                                                                                                                                             
  Yes                                                                                                         35/371 (27)       50/330 (43)        79/667 (25)     115/555 (47)   51/550 (15)     78/506 (24)
  No                                                                                                          96/371 (73)       66/330 (57)        235/667 (75)    126/555 (53)   284/550 (85)    249/506 (76)
  N/A, no sexual activity                                                                                     240/371           214/330            353/667         314/555        215/550         179/506
  Missing                                                                                                     21                17                 26              18             16              6
  Have you taken an initiative to sex with your partner in the last month                                                                                                                         
  Yes                                                                                                         57/241 (24)       43/220 (20)        208/513 (41)    157/424 (37)   190/409 (46)    242/416 (58)
  No                                                                                                          184/241 (76)      177/220 (80)       305/513 (59)    267/424 (63)   219/409 (53)    174/416 (42)
  Not applicable, I have not had any sexual partner within the last month                                     125/366           105/325            153/666         123/547        141/550         91/507
  Missing                                                                                                     26                22                 27              26             16              5
  What is your frequency of sexual activity within the last month                                                                                                                                 
  At least 1--2 times per month                                                                               106/368 (29)      82/329 (25)        270/664 (41)    189/548 (34)   305/553 (55)    302/511 (59)
  None                                                                                                        262/368 (71)      247/329 (75)       394/664 (59)    359/548 (66)   248/553 (45)    209/511 (41)
  Missing                                                                                                     24                18                 29              25             13              1
  Is intercourse a part of your sexual life?                                                                                                                                                      
  Yes                                                                                                         158/356 (44)      64/326 (20)        361/646 (56)    140/544 (26)   329/546 (60)    315/507 (62)
  No                                                                                                          198/356 (56)      262/326 (80)       285/646 (44)    404/544 (74)   217/546 (40)    192/507 (38)
  Missing                                                                                                     36                21                 47              29             20              5
  Are you satisfied with your sexual life within the last month?                                                                                                                                  
  Yes                                                                                                         240/322 (75)      81/116 (70)        411/639 (64)    167/297 (56)   395/523 (76)    331/496 (67)
  No                                                                                                          82/322 (25)       35/116 (30)        228/639 (36)    130/297 (44)   128/523 (24)    165/496 (33)
  Missing                                                                                                     70                22                 54              32             43              16
  Distress if sex problems/erectile dysfunction within the last month would remain the rest of your life?                                                                                         
  Moderate or much distress                                                                                   54/304 (18)       71/295 (24)        270/521 (52)    226/304 (74)   121/535 (23)    173/502 (34)
  No distress                                                                                                 10/304 (3)        13/295 (4)         76/521 (15)     20/304 (7)     38/535 (7)      48/502 (10)
  Not applicable, no problem                                                                                  240/304 (79)      211/295 (72)       175/521 (34)    58/304 (19)    376/535 (70)    281/502 (56)
  Not applicable, no sexual activity/don't know                                                               52/356 (15)       24/319 (8)         117/638 (18%)   234/538 (43)   Not available   Not available
  Missing                                                                                                     36                28                 55              35             31              10
  Has ability to achieve orgasm changed after treatment?                                                                                                                                          
  Ability has not changed                                                                                     --                87/123 (71)                        126/332 (38)   282 (52)        324 (64)
  Harder to achieve orgasm nowadays                                                                                             30/123 (24)                        139/332 (42)   36 (7)          32 (6)
  I can't achieve orgasm                                                                                                        6/123 (5)                          67/332 (20)    18 (3)          13 (3)
  Not applicable, could not before treatment                                                                                    28/320 (9)                         31/529 (6)                      
  Not applicable, have not tried to achieve orgasm                                                                              169/320 (53)                       166/529 (31)   205 (38)        135 (27)
  Missing                                                                                                                       28                                 44             25              8
  Afraid of embarrassment during sexual activity due to the stoma?[\*](#codi14907-note-0006){ref-type="fn"}                                                                                       
  Yes, at least a little                                                                                                        38/67 (57)                         93/150 (62)                     
  No                                                                                                                            29/67 (43)                         57/150 (38)                     
  Not applicable, I am not sexually active                                                                                      111/178 (62)                       196/346 (57)                    
  Missing                                                                                                                       169                                227                             

Number of patients with a stoma 1 year after diagnosis: women 170/331 (51%); men 343/557 (62%).
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![Age‐matched comparison with the reference population.](CODI-22-500-g002){#codi14907-fig-0002}

Quality of sexual life {#codi14907-sec-0020}
----------------------

A majority of the women were satisfied with their sexual life before (75%) and after (70%) treatment). This was also similar to the reference population (74%). Before treatment, men with rectal cancer were similarly content with their sexual life compared with the reference population (64% *vs* 67%), but still less satisfied than women. At 1 year, men with rectal cancer were less satisfied than before treatment (56%) and 74% reported much distress if their sexual dysfunction would remain, compared with 52% before treatment and 34% in the reference population. Women with rectal cancer had low distress at baseline but similar distress to the reference population at 1 year (24% *vs* 23**%)** (Table [3](#codi14907-tbl-0003){ref-type="table"} and Fig. [2](#codi14907-fig-0002){ref-type="fig"}).

In the majority of women, the ability to achieve orgasm did not change over time, but in men 42% experienced problems achieving an orgasm 1 year after diagnosis (Table [3](#codi14907-tbl-0003){ref-type="table"}).

Risk factors for low sexual activity {#codi14907-sec-0021}
------------------------------------

Of all evaluated potential risk factors for low sexual activity after 1 year (Table [4](#codi14907-tbl-0004){ref-type="table"}), being sexually inactive at diagnosis and the presence of a stoma were identified by the regression selection strategy (Table [5](#codi14907-tbl-0005){ref-type="table"}).

###### 

Logistic regression analysis of potential risk factors for absence of intercourse last month 1 year after diagnosis.

  Variable                                          Category                Intercourse frequency last month   Comparison              Bivariate regression[\*](#codi14907-note-0008){ref-type="fn"}   Multiple regression                                             
  ------------------------------------------------- ----------------------- ---------------------------------- ----------------------- --------------------------------------------------------------- --------------------- ------------------- --------------------- -----------
  Intercourse frequency last month, at diagnosis    Once or more frequent   202 (64)                           114 (36)                Never *vs* once or more frequent                                16.67 (11.11; 25.0)   \< 0.0001           16.67 (11.11; 25.0)   \< 0.0001
  Never                                             49 (10)                 454 (90)                                                                                                                                                                                   
  Missing                                           20                      38                                                                                                                                                                                         
  UICC                                              UICC 0                  2 (14)                             12 (86)                                                                                                                                                  
  UICC I                                            76 (33)                 153 (67)                           I *vs* II               1.18 (0.71; 1.99)                                               0.5205                1.10 (0.64; 1.89)   0.7371                
  UICC II                                           63 (35)                 116 (65)                           I *vs* IV               0.86 (0.44; 1.686)                                              0.6611                0.72 (0.30; 1.72)   0.4583                
  UICC III                                          66 (28)                 172 (72)                           II *vs* III             0.60 (0.36; 0.99)                                               0.0495                0.48 (0.25; 0.91)   0.0255                
  UICC IV                                           26 (29)                 64 (71)                            II *vs* IV              0.73 (0.36; 1.45)                                               0.3664                0.66 (0.28; 1.57)   0.3425                
  Missing                                           38                      89                                                                                                                                                                                         
  Preoperative CRT                                  No                      216 (31)                           475 (69)                No *vs* yes                                                     0.75 (0.48; 1.18)     0.2110              0.75 (0.38; 1.48)     0.4123
  Yes                                               54 (29)                 131 (71)                                                                                                                                                                                   
  Missing                                           1                                                                                                                                                                                                                  
  Preoperative RT                                   No                      174 (32)                           378 (68)                No *vs* yes                                                     0.88 (0.61; 1.28)     0.5092              0.98 (0.61; 1.58)     0.9384
  Yes                                               96 (30)                 228 (70)                                                                                                                                                                                   
  Missing                                           1                                                                                                                                                                                                                  
  Postoperative CT                                  No                      153 (29)                           366 (7)                 No *vs* yes                                                     1.05 (0.73; 1.52)     0.8004              1.70 (0.96; 3.00)     0.0668
  Yes                                               117 (3)                 238 (67)                                                                                                                                                                                   
  Missing                                           1                       2                                                                                                                                                                                          
  Surgical technique and colostomy                  1: APE                  78 (28)                            196 (72)                1 *vs* 2                                                        1.66 (1.08; 2.55)     0.0212              1.57 (0.94; 2.61)     0.0846
  2: AR, other or no surgery, no stoma              128 (38)                206 (62)                           1 *vs* 3                0.78 (0.46; 1.30)                                               0.3359                0.83 (0.46; 1.48)   0.5886                
  3: AR, Hartmann, other or no surgery, stoma yes   52 (25)                 157 (75)                           2 *vs* 3                0.47 (0.29; 0.77)                                               0.0026                0.53 (0.31; 0.91)   0.0164                
  Missing                                           13                      47                                                                                                                                                                                         
  Technique                                         Open                    108 (29)                           264 (71)                                                                                                                                                 
  Laparoscopy                                       138 (34)                264 (66)                           Laparoscopy *vs* open   0.89 (0.61; 1.29)                                               0.5369                1.03 (0.67; 1.57)   0.9027                
  Missing                                           25                      78                                                                                                                                                                                         
  Would you call yourself depressed?                No                      238 (32)                           515 (68)                No *vs* yes/don't know                                          0.88 (0.50; 1.55)     0.6542              0.77 (0.39; 1.50)     0.4438
  Yes/don't know                                    31 (26)                 87 (74)                                                                                                                                                                                    
  Missing                                           2                       4                                                                                                                                                                                          

APE, abdominoperineal excision; AR, lower anterior resection; CRT, chemoradiotherapy; CT, chemotherapy; Hartmann, Hartmann's procedure; RT, radiotherapy; UICC, Union Internationale Contre le Cancer.

Intercourse frequency at diagnosis is included as a covariate.

Modelling the probability of no intercourse in the last month.

John Wiley & Sons, Ltd

###### 

Multiple logistic regression analysis for the variables chosen by the selection strategy[\*](#codi14907-note-0011){ref-type="fn"}.

  Variable                                                                   Comparison                         Without imputations   With imputations                          
  -------------------------------------------------------------------------- ---------------------------------- --------------------- ------------------- --------------------- -----------
  Intercourse frequency last month, at diagnosis                             Never *vs* once or more frequent   16.67 (11.11; 25.0)   \< 0.0001           14.29 (9.09; 20.00)   \< 0.0001
  Surgical technique and colostomy[‡](#codi14907-note-0013){ref-type="fn"}   1 *vs* 2                           1.66 (1.08; 2.55)     0.0212              1.58 (1.05; 2.38)     0.0273
  1 *vs* 3                                                                   0.78 (0.46; 1.30)                  0.3359                0.84 (0.51; 1.38)   0.4856                
  2 *vs* 3                                                                   0.47 (0.29; 0.77)                  0.0026                0.53 (0.33; 0.84)   0.0082                

APE, abdominoperineal excision; AR, lower anterior resection; Hartmann, Hartmann's procedure.

Modelling the probability of no intercourse in the last month.

Pooled estimates based on multiple imputations by chained equations.

1, APE; 2, AR, Hartmann, other or no surgery, no stoma; 3, AR, Hartmann, other or no surgery, stoma yes.

John Wiley & Sons, Ltd

Information and treatment for sexual dysfunction {#codi14907-sec-0022}
------------------------------------------------

Most patients did not remember receiving any information regarding possible sexual dysfunction after treatment at the 1‐year follow‐up. Women experienced to a larger extent that they had not been informed. Only 14% of the men and 4% of the women had sought help for their sexual dysfunction (Table [6](#codi14907-tbl-0006){ref-type="table"}).

###### 

Information and medical assistance.

  Category                                                                   Women (at baseline) (*n* = 392)   Women (1 year after diagnosis) (*n* = 347)   Men (at baseline) (*n* = 693)   Men (1 year after diagnosis) (*n* = 573)
  -------------------------------------------------------------------------- --------------------------------- -------------------------------------------- ------------------------------- ------------------------------------------
  Information about sexual dysfunction after treatment for rectal cancer                                                                                                                    
  Yes                                                                        59/378 (16)                       67/326 (21)                                  189/675 (28)                    148/546 (27)
  No                                                                         319/378 (84)                      249/326 (76)                                 486/675 (72)                    377/546 (69)
  Don't remember/know                                                                                          10/326 (3)                                                                   21/546 (4)
  Missing                                                                    14                                21                                           18                              27
  Sought medical support after treatment?                                                                                                                                                   
  Yes                                                                                                          8/210 (4)                                                                    60/437 (14)
  No                                                                                                           129/210 (61)                                                                 293/437 (67)
  Not applicable, I have no problems                                                                           73/210 (34)                                                                  84/437 (19)
  Not applicable, I have not had any sexual activity within the last month                                     110/320 (34)                                                                 106/543 (20)
  Missing                                                                                                      27                                                                           30

John Wiley & Sons, Ltd

Discussion {#codi14907-sec-0023}
==========

This study shows that sexual activity is low in an unselected cohort of patients with rectal cancer at the time of diagnosis and even lower 1 year later. It is also obvious that many patients experience that they have not received information regarding the likely effects of treatment on sexual function.

In our study, sexual dysfunction was not as pronounced as previously reported at 1 year [9](#codi14907-bib-0009){ref-type="ref"}, [10](#codi14907-bib-0010){ref-type="ref"}, [14](#codi14907-bib-0014){ref-type="ref"}, [29](#codi14907-bib-0029){ref-type="ref"}. Just as described by a recently developed short form for the evaluation of female sexual activity in patients with rectal cancer [11](#codi14907-bib-0011){ref-type="ref"}, we found that insufficient lubrication and swelling are also common problems both at diagnosis and after 1 year. Interestingly, dyspareunia was similar in female patients at baseline and the reference population although this almost doubled after 1 year, suggesting a clear negative effect from the treatment.

Even though the prevalence of dysfunction was high it is evident that most women were content with their sexual life. This highlights that satisfaction may be related to other issues, such as the level of expectation. Possibly, the high level of retained ability to achieve an orgasm in women after treatment could be a part of the reason for the degree of satisfaction in this group. Interestingly, men were less satisfied and they also had twice as frequent problems achieving an orgasm. Both men and women felt insufficiently informed about their possible sexual dysfunction. Still, women were fairly pleased, indicating that lack of information did not affect their experience of their sexual life.

The twofold higher prevalence of erectile dysfunction at diagnosis among patients with rectal cancer compared with the reference population indicates that our patient cohort is somewhat older and that erectile dysfunction may also be related to other factors than nerve damage and the surgical procedure. Interestingly, 95% of the men answered the questions regarding erectile dysfunction although other answers indicated that not all of these patients were in fact sexually active. Our figures on erectile dysfunction are similar to or lower than previously reported [8](#codi14907-bib-0008){ref-type="ref"}, [9](#codi14907-bib-0009){ref-type="ref"}.

The risk of erectile dysfunction should be addressed when counselling patients, and our study indicates that information to patients remains insufficient. Not more than 28% of the men and 16% of the women experienced that they had been informed about the possible side effects on their sexual function at diagnosis. This was similar after 1 year and very few patients had sought medical treatment. There are data indicating that men with post‐treatment sexual dysfunction may benefit from sildenafil [34](#codi14907-bib-0034){ref-type="ref"} and that this should be initiated soon after treatment. For women, assistance with lubrication and counselling regarding dyspareunia could improve their sexual function [35](#codi14907-bib-0035){ref-type="ref"}. Our data show that we need to raise awareness among caregivers that patients do not receive sufficient information.

Sexual activity was lower in patients with rectal cancer compared with the reference population, both at baseline and at the 1‐year follow‐up. This is not surprising as a Dutch study that focused on patients and their partners at diagnosis revealed a reduced sexual activity and quality at diagnosis [36](#codi14907-bib-0036){ref-type="ref"} and there are other studies that have found similar sexual frequency to ours in patients after treatment [14](#codi14907-bib-0014){ref-type="ref"}. Still, there are other studies that indicate that our patients were less sexually active at baseline than previously reported [8](#codi14907-bib-0008){ref-type="ref"}, [11](#codi14907-bib-0011){ref-type="ref"}. In part, this may be due to the slightly younger cohort in these studies but it may also be due to recall bias in cross‐sectional cohorts [11](#codi14907-bib-0011){ref-type="ref"}.

Sexual dysfunction after rectal cancer treatment is a multifactorial problem with a broad spectrum of associated risk factors [20](#codi14907-bib-0020){ref-type="ref"}, [37](#codi14907-bib-0037){ref-type="ref"}. Psychological factors such as libido, arousal, body image and self‐esteem may be important [11](#codi14907-bib-0011){ref-type="ref"}, [38](#codi14907-bib-0038){ref-type="ref"}. The presence of a stoma seems to affect sexual life for many patients, and improved counselling both before and after surgery by stoma care therapists as well as other healthcare personnel may help these patients.

A strength of this study is the prospective, unselected, multicentre design. Patients have been included regardless of curative or palliative intent. We previously compared the cohort to all patients admitted to the including hospitals, and it is a representative cohort of daily clinical activity [22](#codi14907-bib-0022){ref-type="ref"}. The large cohort together with good response rates at baseline and at 1‐year follow‐up are also considered strengths. The multicentre design with almost no exclusion factors gives high external validity. The reference population is a strength, as it was collected during the same time frame as the study. We used a recall period of 1 month in the questionnaire and this may cause a bias regarding sexual function as it is not evaluated in patients with low sexual frequency. However, a longer recall period is also problematic as it may introduce recall bias. It is important that patients can find a response option that applies to them, and thus the answer 'Not applicable, I have not had any sexual activity' has a value in itself.

In conclusion, regardless of gender, low sexual activity 1 year after diagnosis and treatment for rectal cancer is not only related to the diagnosis but also to factors that are unrelated to the disease. The presence of a stoma seems to be of importance and measures to facilitate patients with permanent or temporary stomas regaining their sexual activity must be a focus. Preoperative information about sexual dysfunction after treatment for rectal cancer should be improved.
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